| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Propanc Biopharma, Inc. [ PPCB ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 07/05/2023 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 2,805(1)(2) | D | ||||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Common Stock Purchase Warrant | $0.01 | 07/05/2023 | A | 15,000,000(3) | 07/05/2023 | 07/05/2026 | Common Stock | 15,000,000 | $0(4) | 15,000,000(3) | I | By Aggro Investments Pty Ltd(3) | |||
| Explanation of Responses: |
| 1. On May 1, 2023, the issuer effected a 1-for-1,000 reverse stock split (the "Reverse Split") of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"). The number of shares of Common Stock reported on this Form 4 has been adjusted to reflect the Reverse Split as it pertained to the number of shares of Common Stock that the reporting person held immediately following the Reverse Split. |
| 2. The reporting person's Form 3 filed on August 20, 2021 inadvertently failed to report an additional 5 shares of Common Stock directly owned in error. Due to the method of rounding fractional shares of Common Stock held by the reporting person after the Reverse Split, the number of shares of Common Stock reported on this Form 4 has also been adjusted to correct the reporting person's total ownership as of August 23, 2023. |
| 3. Due to an administrative error, the reporting person inadvertently failed to report the beneficial ownership of the common stock purchase warrant (the "Warrant") issued to Aggro Investments Pty Ltd ("Aggro Investments") on July 5, 2023. The Warrant is currently exercisable, with shares of Common Stock issuable upon exercise subject to a 4.99% blocker based upon the aggregate number of shares of Common Stock outstanding on the date of such exercise. The reporting person wholly owns and controls Aggro Investments, but disclaims beneficial ownership of the Warrant and shares issuable pursuant to its exercise, except to the extent of the reporting person's pecuniary interest therein. |
| 4. Reflects the receipt of the Warrant for no additional consideration in connection with a loan from Aggro Investments to the issuer on July 5, 2023. |
| /s/ Josef Zelinger | 08/23/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
